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Introduction {#sec1}
============

The transcription cycle consists of three stages. Initiation, where RNA polymerase engages with the DNA template, followed by elongation where it translocates along the DNA template synthesizing the RNA copy of the gene and finally termination, where polymerase disengages from the DNA template. In mammals, promoter and terminator DNA sequences are well described for genes transcribed by RNA polymerases I and III ([@bib19]). For genes transcribed by RNA polymerase II (Pol II), including all protein coding genes, there is an extensive literature describing promoter sequences. The Mammalian Promoter Database lists 24,967 known and an additional 17,926 potential human Pol II promoters ([@bib7]); however, fewer than ten verified mammalian Pol II terminator sequences have been described ([@bib16]; [@bib19]).

The major reason for this discrepancy is that Pol II termination is coupled to the complex steps involved in pre-mRNA processing and is entirely dependent upon the presence of a functional poly(A) signal ([@bib28]; [@bib4]). Pre-mRNA cleavage at the poly(A) site, mediated by the 3′ end processing complex ([@bib20]), generates two RNA products; a 5′ cleavage product that is stabilized by polyadenylation as it is processed into mRNA and a 3′ cleavage product that is subject to rapid degradation by the 5′-3′ exonuclease Xrn2. Such Xrn2-mediated transcript degradation has been shown to have a role in Pol II termination ([@bib24]). The above could lead one to conclude that the poly(A) site sequence, typically characterized by the hexanucleotide sequence AATAAA followed by a GU/U rich region ([@bib17]), is the sole Pol II terminator signal. That this is indeed the case, in lower eukaryotes, is supported by a number of studies, mainly in yeast, which provide a detailed understanding of the roles of a host of RNA processing factors in the Pol II termination process ([@bib19]; [@bib10]). For mammalian genes, however, the poly(A) signal is not the only sequence that is required for Pol II termination. Studies in our laboratory and others have shown the existence of dedicated DNA-encoded Pol II terminator elements located downstream of poly(A) signals ([@bib16]; [@bib22]; [@bib5]; [@bib15]; [@bib6]; [@bib25]). From these studies, it appears that there are two broad categories of terminator sequence; G-rich sequences that enhance poly(A) site cleavage and subsequent Pol II termination by pausing Pol II near to the poly(A) signal ([@bib18]; [@bib6]) and AT-rich terminator sequences, located 1--2 kb downstream of the poly(A) site, which mediate rapid cotranscriptional cleavage of nascent transcripts, prior to poly(A) site cleavage ([@bib5]; [@bib15]; [@bib25]). RNA degradation initiating at cotranscriptional cleavage (CoTC) sites leads to release of Pol II and associated unprocessed pre-mRNA, from the DNA template ([@bib26]). This distinguishing feature of CoTC-mediated termination is supported by electron microscopic studies in *Drosophila* that show that release of pre-mRNA from transcription sites prior to 3′ end processing is a common occurrence ([@bib14]).

One of the major reasons for the paucity of mammalian Pol II terminator sequences in the literature is that examination of termination mechanisms is hindered by the technical difficulty of mapping nascent transcripts in nuclear run on experiments ([@bib16]). Here we have used a CLIP-seq strategy ([@bib11]) to distinguish pre-mRNAs that are released from the DNA template before cleavage at the poly(A) site, in order to identify genes that utilize the CoTC termination pathway. Thorough testing of potential terminator sequences from a number of candidate gene loci shows that we have isolated authentic Pol II terminators and indicates that CoTC-mediated termination is a feature of a significant proportion of mammalian genes.

Results {#sec2}
=======

CLIP-seq-Based CoTC Terminator Mapping Strategy {#sec2.1}
-----------------------------------------------

Detailed transcriptional analysis of the human β-globin gene has shown that CoTC of β-globin 3′ flanking region transcripts leads to release of Pol II and associated pre-mRNA, from the chromatin template prior to cleavage/polyadenylation at the poly(A) site. Interestingly, 3′ end processing of these released pre-mRNAs (referred to herein as unprocessed pre-mRNAs) occurs posttranscriptionally, in the nucleoplasm ([Figure 1](#fig1){ref-type="fig"}A) ([@bib26]). Following on from these observations, we have developed a strategy, using in vivo UV crosslinking immunoprecipitation (IP) with antibody to the CstF-64 pre-mRNA processing factor ([@bib12]), to select such unprocessed nucleoplasmic pre-mRNAs in order to identify genes that use the CoTC termination pathway.

In an initial pilot experiment, HeLa cells transiently transfected with a β-globin minigene construct βTERM (that has an HIV-LTR promoter) and a plasmid encoding the viral transactivator Tat (pTat), were subjected to UV crosslinking followed by nuclear fractionation into chromatin (Ch) and nucleoplasm (N) fractions, as described previously ([@bib26]). IP was then conducted on the nucleoplasm fraction using CstF-64 antibody to precipitate unprocessed β-globin pre-mRNA, which was detected by RT-PCR using β-globin and control 7SK snRNA primers ([Figure 1](#fig1){ref-type="fig"}B). In lane 1, the detection of PCR products representing unprocessed β-globin pre-mRNA and mature 7SK transcripts, confirms the presence of both RNA species in the input nucleoplasm fraction. In control lane 2, no PCR products are detected confirming that 7SK and β-globin pre-mRNA do not interact with IgG. In lane 3, RT-PCR of nucleoplasmic RNA precipitated with the CstF-64 antibody shows the presence of a PCR product for β-globin but not 7SK, confirming a specific interaction of CstF-64 with nucleoplasmic β-globin pre-mRNA.

We next performed CstF-64 IP, combined with high throughput sequencing (CLIP-seq) ([@bib11]), to identify endogenous CstF-64 interacting nucleoplasmic pre-mRNAs. HeLa cells transiently transfected with βTERM and pTat were UV crosslinked prior to nuclear fractionation. The nucleoplasm fraction was then treated with high (40 U/ml; lanes 1--4) or low (4 U/ml; lanes 5--8) RNaseI before IP with CstF-64 and IgG antibodies. Immunoprecipitated RNA was 5′ end-labeled with \[γ-^32^P\] ATP and protein RNA complexes were separated by PAGE and transferred to a nitrocellulose membrane ([Figure 1](#fig1){ref-type="fig"}C). IP of UV-treated cells with CstF-64 antibody (lanes 4 and 8) results in two prominent radiolabeled bands. (The absence of bands in control lanes 1--3 and 5--7, confirms the specificity of the CstF-64 IP experiment; see legend for full details). The lower 70 kDa band is the expected size for CstF-64 and the upper ∼200 kDa band is possibly a CstF-64 dimer. The bands detected in lane 8 (4 U/ml) are relatively weaker than those detected in lane 4 (40 U/ml) and appear within a radioactive smear extending from 40--300 kDa, which reflects partial RNA digestion due to limiting RNaseI. RNA was eluted from the membrane at a position 20--30 kDa above the 70 kDa CstF-64 band to obtain CstF-64/RNA complexes containing 50--80 nucleotide (nt) RNAs. Eluted RNAs were ligated to adaptors for reverse transcription and PCR amplification. This experiment was repeated twice more on untransfected cells. PCR products from each experiment were analyzed by high throughput sequencing (HITS). A total of 1,285 CLIP regions were identified, from the three repeats, which were supported by at least two independent read alignments in the pooled samples. These CLIP regions were significantly enriched in genic (RefSeq+RNA genes) but not intergenic regions and within genes, they showed significant enrichment in extended 3′ UTR regions, but not in exons or introns (graphs, [Figure 1](#fig1){ref-type="fig"}D). Seventy-eight genes ([Table 1](#tbl1){ref-type="table"}) containing CstF-64 CLIP regions within 3′ UTRs (i.e., in proximity to putative poly(A) sites) were selected as CoTC candidates (see [Experimental Procedures](#sec4){ref-type="sec"} for details). Importantly, this list contains the β-globin gene, as three unique CLIP reads were mapped in the proximity of its annotated poly(A) site, in the transfected sample ([Figure 1](#fig1){ref-type="fig"}E).

CLIP-seq Positive Candidate Pre-mRNAs Are Released from the DNA Template {#sec2.2}
------------------------------------------------------------------------

According to our hypothesis, the detection of a particular unprocessed pre-mRNA in the nucleoplasm is a marker of CoTC-type termination occurring at the corresponding gene locus. Therefore, to further test the CLIP-seq data, we analyzed the nuclear distribution of unprocessed pre-mRNA, from a subset of CLIP-seq positive genes, by quantitative radioactive RT-PCR (qRT-PCR) of chromatin and nucleoplasm fractions ([Figure 2](#fig2){ref-type="fig"}A). Analysis of pre-mRNA in the chromatin (Ch) fraction (lane 1) shows that unprocessed, presumably nascent, pre-mRNAs are detected at each of the candidate gene loci. Likewise, for the nucleoplasm (N) fraction (lane 2), unprocessed pre-mRNA from each of the candidate gene loci is detected. Quantitative analysis of the PCR products, in lanes 1 and 2, confirms that significant amounts of unprocessed pre-mRNA (19%--55%) are released to the nucleoplasm fraction from the corresponding gene loci ([Figure 2](#fig2){ref-type="fig"}A, graph). Variation in the amount of nucleoplasmic pre-mRNA, from different genes, may indicate variation in the efficiency of pre-mRNA release, gene-specific rates of 3′ end processing or differential RNA stability. Importantly, these data confirm our detection of unprocessed nucleoplasmic pre-mRNAs in our CLIP-seq analysis and support the hypothesis that a CoTC-type termination mechanism operates at these gene loci.

To control for the possibility that the presence of unprocessed nucleoplasmic pre-mRNA is a general feature of Pol II transcribed genes, we employed the same qRT-PCR strategy to examine the nuclear distribution of *GAPDH*, *PKM2*, and *ENO1* pre-mRNAs, as these highly expressed transcripts ([@bib9]) were not detected in our CLIP-seq analysis. As shown in [Figure 2](#fig2){ref-type="fig"}B, analysis of pre-mRNAs in the chromatin (Ch) fraction (lane 1) detected unprocessed, presumably nascent, pre-mRNAs at each of the candidate gene loci. In lane 2, analysis of the nucleoplasm fraction detected only faint PCR products representing unprocessed nucleoplasmic pre-mRNAs from these gene loci. Quantitative analysis of the radiolabeled RT-PCR products derived from chromatin and nucleoplasm fractions (graph, [Figure 2](#fig2){ref-type="fig"}B) shows that unprocessed nucleoplasmic pre-mRNAs represent merely 4%--7% of total pre-mRNA from these gene loci. These data provide further validation of the CLIP-seq experiment and indicate that, on the basis of our selection criteria (detection of unprocessed nucleoplasmic pre-mRNA), it is likely that the *GAPDH*, *PKM2*, and *ENO1* genes do not employ a CoTC termination mechanism. We predict that the termination mechanism employed at these gene loci is similar to the previously described pause-type, where poly(A) site cleavage precedes Pol II release from the DNA template ([@bib6]; [@bib26]) (diagram, [Figure 2](#fig2){ref-type="fig"}B).

Mapping of Terminator Elements at CLIP-seq Positive Gene Loci {#sec2.3}
-------------------------------------------------------------

We next developed a strategy to map terminator elements at the CLIP-seq positive gene loci. Transcript cleavage occurring downstream of and prior to cleavage at the poly(A) site is an intrinsic part of the CoTC terminator mechanism ([@bib5]; [@bib26]) ([Figure 1](#fig1){ref-type="fig"}A). Therefore we reasoned that it would be possible to infer the location of potential CoTC terminator sequences, in the 3′ flanking regions of CLIP-seq positive genes, by mapping sites of transcript cleavage using an RT-PCR approach. Total nuclear RNA was reverse transcribed using random primers and the resulting cDNA was PCR amplified using gene-specific primers complementary to 3′ flanking region transcripts. For *CCNB1*, PCR amplification was carried out using a single forward primer (F), located upstream of the *CCNB1* poly(A) site, in combination with reverse primers (R1--R5) located at increasing distance downstream of the poly(A) site in the *CCNB1* 3′ flanking region ([Figure 3](#fig3){ref-type="fig"}A, diagram). PCR amplification using the F/R1-R3 primer pairs resulted in the detection of 180 bp, 580 bp, and 1.1 kb bands (lanes 6--8), which correspond precisely to bands derived from control amplification of genomic DNA using the same primer pairs (lanes 1--3). PCR amplification using F/R4 and F/R5 primer pairs does not result in detectable levels of product (lanes 9 and 10), even though corresponding PCR products are derived from control amplification of genomic DNA (lanes 4 and 5). Thus RT-PCR analysis shows that continuous *CCNB1* pre-mRNA is detected up to ∼1.1 kb downstream of the poly(A) site (lane 8, F/R3 primer pair), with no continuous RNA detected beyond this point (lanes 9 and 10). From these data, we estimated that a potential CoTC terminator element (PCTE) was located between 470--1,780 bp downstream of the *CCNB1* poly(A) site (the region bordered by primers R2 and R4). This observation is similar to that reported for the β-globin gene, where significant CoTC activity occurs at a position ∼1.0 kb downstream of the β-globin poly(A) site ([@bib5]). We next adopted the same terminator mapping strategy for four other CLIP-seq positive genes (*AKIRIN1*, *PTCH2*, *THOC2*, and *WDR13*). Transcript cleavage (3′ flanking region) was mapped to positions 0.8--1.2 kb downstream of the respective poly(A) sites and was used to estimate the location of PCTEs ([Figure 3](#fig3){ref-type="fig"}B). Confirmation of these results comes from control experiments, measuring RT-PCR efficiency on full-length in vitro transcribed *CCNB1*, *PTCH2*, and *WDR13* 3′ flanking region transcripts ([Figure S1](#figs1){ref-type="fig"}).

Testing Candidate Terminator Elements {#sec2.4}
-------------------------------------

The five newly identified PCTEs were placed in the termination reporter plasmid (βΔTERM) and tested for terminator activity by RNase protection assay (RPA) ([@bib15]). Nuclear RNA isolated from HeLa cells transiently transfected with each of the candidate reporter constructs, positive (βTERM), or negative (βΔTERM) terminator control constructs and pTat, was hybridized to an antisense radiolabeled riboprobe spanning the reporter gene HIV-LTR ([Figure 4](#fig4){ref-type="fig"}A). Following RNase digestion, protected products were analyzed by PAGE ([Figure 4](#fig4){ref-type="fig"}B). In lane 1, no protection products were detected, confirming the absence of β-globin mRNA in untransfected HeLa cells. In lane 2 (βTERM), the prominent 85 nt band, (labeled mRNA) at the base of the gel, results from hybridization of the riboprobe to the 5′ end of the β-globin mRNA. The weaker 242 nt band (labeled RT) results from hybridization of the riboprobe to read-through transcripts derived from Pol II transcription proceeding around the plasmid into the HIV-LTR. In lane 3 (βΔTERM), a weaker mRNA band was detected together with a prominent read-through band that reflects increased Pol II read-through transcription in the absence of the β-globin terminator element. In lane 4 (βCCNB1), the reduced intensity of the read-through band shows that the *CCNB1* PCTE effectively blocks Pol II read-through transcription. Furthermore, the corresponding increase in the mRNA band shows that β-globin mRNA recovers to wild-type level in the presence of the *CCNB1* PCTE. The low level of the read-through band in all candidate PCTE samples (lanes 5--8 and graph below the data panel) indicates that each PCTE has terminator activity.

Although RPA is useful for screening terminator activity, it is an indirect method and read-through transcript levels could be affected by differential RNA stability. Therefore, we next employed nuclear run on (NRO) analysis to measure termination by the *CCNB1* and *PTCH2* PCTEs. NRO analysis was conducted on nuclei isolated from HeLa cells transfected with βCCNB1, βPTCH2, and three control constructs (βTERM, βΔTERM, and β4-7) along with pTat. Resulting radiolabeled nascent transcripts were hybridized to the nylon filter shown in [Figure 4](#fig4){ref-type="fig"}C. For the positive control construct (βTERM) prominent hybridization signals are detected in the gene body and post poly(A) site region (probes P, B3, and B4, respectively) and background level signals are detected over probes A and U3, which are located downstream of the terminator, showing that efficient termination occurs before Pol II reaches region A of the plasmid template ([@bib5]). For the termination negative control (βΔTERM), in the absence of the terminator sequence, hybridization signals are detected over all probes P-U3. The presence of prominent signals over probes A and U3 shows that in the absence of the terminator Pol II transcribes the entire plasmid. The transcription profiles resulting from NRO analysis of βCCNB1 and βPTCH2 are essentially identical to βTERM, with prominent radioactive signals detected over probes P, B3 and B4 and only background level signal over probes A and U3. NRO analysis of control construct β4-7, which includes an 850 bp spacer sequence in place of the terminator, confirms that the effect of *CCNB1* and *PTCH2* PCTEs on the NRO profile is due to the presence of authentic Pol II terminator signals and not to arbitrary spacing effects.

The *CCNB1* Terminator Mediates CoTC Activity {#sec2.5}
---------------------------------------------

Having confirmed that a subset of PCTEs mediate efficient Pol II termination, we next conducted further analysis of two PCTEs to measure CoTC activity. Detailed analysis of the human β-globin CoTC terminator shows that cotranscriptional cleavage of terminator transcripts precedes Pol II disengagement from the DNA template ([Figure 1](#fig1){ref-type="fig"}A) ([@bib5]; [@bib26]). To determine if a similar order of events occurs at the *CCNB1* terminator, we began by measuring the distribution of transcribing Pol II in the endogenous *CCNB1* terminator region, by qRT-PCR analysis of nascent transcripts. Total nuclear RNA was reverse transcribed using random primers and the resulting cDNA was PCR amplified, using primer pairs to detect transcripts of the *CCNB1* poly(A) site and terminator regions (see upper diagram, [Figure 5](#fig5){ref-type="fig"}A). The resulting PCR products were quantified by PhosphoImage analysis before plotting on the graph (gray bars, [Figure 5](#fig5){ref-type="fig"}A). PCR amplification, using primer pair F1/R1, results in a prominent signal reflecting the high abundance of transcripts in the poly(A) site region. PCR amplification of cDNA representing *CCNB1* terminator transcripts, using primer pair F2/R2, indicates relatively high transcript abundance at the 5′ end of the terminator. However, transcript abundance is significantly decreased by the middle of the terminator, primer pair F3/R3, falling to ∼10% at the 3′ end of the terminator element (primer pair F4/R4). Examination of the post-terminator region, using primer pair F5/R5, indicates a further decrease in active Pol II level. These data show that the level of transcriptionally engaged Pol II decreases as it proceeds through the terminator region, indicative of Pol II termination. We next examined the continuity of *CCNB1* terminator transcripts by qPCR of random primed cDNA, using primer pairs composed of a single forward primer (F1), located immediately upstream of the *CCNB1* poly(A) site, in combination with five different reverse primers (R1--R5; see lower diagram, [Figure 5](#fig5){ref-type="fig"}A). The resulting radioactive PCR products were quantified by PhosphoImage analysis before plotting on the graph (black bars, [Figure 5](#fig5){ref-type="fig"}A). This analysis shows that whereas high levels of continuous transcripts are detected with reverse primers positioned before the terminator element, very few or none (7%--0%) are detected with primers positioned within or downstream of the terminator element. These data show that nascent transcripts of the 5′ end of the *CCNB1* terminator are cotranscriptionally cleaved and, when combined with results from the measurement of transcript distribution above, indicate that transcript cleavage precedes Pol II termination occurring throughout the *CCNB1* terminator. The profile of transcript discontinuity followed by Pol II termination is similar to that described for the human β-globin gene terminator ([@bib5]) and is indicative of the presence of the CoTC termination mechanism at the *CCNB1* gene locus. To test if other candidate genes utilize the CoTC termination pathway we conducted analogous qRT-PCR terminator transcript analysis on the endogenous *WDR13* gene and observed terminator transcript discontinuity occurring before Pol II termination, again indicating the presence of the CoTC termination mechanism ([Figure S2](#figs2){ref-type="fig"}).

Terminator and CoTC Activities Localize to the 5′ End of the *CCNB1* Terminator Element {#sec2.6}
---------------------------------------------------------------------------------------

To analyze the *CCNB1* terminator in more detail, it was divided into three subfragments (labeled A, B, and C) that were placed in the reporter plasmid βΔTERM, forming βCCNB1A, βCCNB1B, and βCCNB1C (diagram, [Figure 5](#fig5){ref-type="fig"}B). The termination capacity of each subfragment was compared to that of the full-length *CCNB1* terminator (in βCCNB1) by RPA. Nuclear RNA isolated from HeLa cells transiently transfected with βCCNB1/A/B and C, positive (βTERM) and negative (βΔTERM) control constructs and pTat, were hybridized to an antisense radiolabeled riboprobe spanning the HIV-LTR ([Figure 5](#fig5){ref-type="fig"}B). The positive (βTERM, lane 2) and negative (βΔTERM, lane 3) controls show that βTERM promotes efficient Pol II termination, as indicated by the reduced read-through signal in lane 2. In lane 4 (βCCNB1), restoration of read-through and mRNA protection products, to the levels seen with the termination positive control βTERM (lane 2), confirms that the full *CCNB1* terminator mediates efficient Pol II termination. In lane 5 (βCCNB1A) a similar pattern of low read-through and high mRNA signal is observed, indicating that region A of the *CCNB1* terminator mediates efficient Pol II termination. In lanes 6 (βCCNB1B) and 7 (βCCNB1C), the significantly lower level of the mRNA band and higher level of the read-through band indicates that regions B and C of the *CCNB1* terminator have reduced terminator activity. This observation is confirmed by quantitative phosphoImage analysis of the radiolabeled protection products, shown in the graph below the data panel.

We next tested the *CCNB1* terminator subfragments for CoTC activity by measuring transcript abundance using qRT-PCR. Nuclear RNA isolated from HeLa cells transiently transfected with βCCNB1/A, B, or C and pTat, was reverse transcribed with PCR primers labeled BR and terR, which are complementary to plasmid sequence either side of the inserted *CCNB1* terminator subfragments (diagram, [Figure 5](#fig5){ref-type="fig"}C). We then conducted PCR on the resultant cDNA using primer pairs BF/BR and terF/terR to analyze transcripts from upstream of and across the terminator subfragments ([Figure 5](#fig5){ref-type="fig"}C). The absence of PCR products in lane 1 confirms that there is no background signal in untransfected HeLa cells. In lane 2 (βCCNB1A) amplification with the BF/BR primer pair yields a prominent PCR product, representing transcripts from upstream of terminator subfragment A. However, PCR amplification of the region A transcript, with the terF/terR primer pair, results in a very low abundance PCR product indicating that few continuous RNA transcripts extend across this region. In contrast, βCCNB1/B and C generated prominent PCR products with both primer pairs, indicating that abundant continuous RNA transcripts extend across these subfragments of the CCNB1 terminator. The very low level of RT-PCR product representing transcripts of subfragment A indicates that they are subject to CoTC. The correspondence of the robust terminator activity of subfragment A, shown by RPA ([Figure 5](#fig5){ref-type="fig"}B), and the observed discontinuity of its transcript, shown both here (lane 2, [Figure 5](#fig5){ref-type="fig"}C) and in qRT-PCR of terminator transcripts from the endogenous gene locus ([Figure 5](#fig5){ref-type="fig"}A), contrasts with the weak terminator activity and apparent stability of region B and C transcripts. These data provide further compelling evidence that Pol II termination on the *CCNB1* gene is mediated by the CoTC termination mechanism and confirm that, using the CLIP-seq strategy, we have successfully identified authentic Pol II terminator elements.

Bioinformatic Analysis of CoTC Terminator Sequences {#sec2.7}
---------------------------------------------------

In order to search for conserved DNA or RNA sequences involved in the CoTC termination mechanism we next conducted a detailed bioinformatic analysis of the 3′ flanking regions (0--2 kb downstream of the CLIP-seq sites) of all 78 CoTC candidate genes. From this analysis we found that candidate gene 3′ flanking regions are slightly more AT- and T-rich than equally sized regions downstream of the annotated pA sites of other protein coding genes ([Figure S3](#figs3){ref-type="fig"}). This finding is in agreement with our analysis of the β-globin terminator that has shown the importance of AT rich sequences in CoTC-mediated termination of β-globin gene transcription ([@bib5]; [@bib27]). Next, in an effort to identify possible *trans*-acting factors in the CoTC termination process, we screened the candidate gene 3′ flanking regions for the presence of DNA binding motifs of known transcription factors represented in the professional version of the TRANSFAC database, which includes 1,665 binding motif matrices. We found that none of these motifs were significantly enriched or depleted in the tested set when compared to the corresponding region of other protein coding genes. Finally, we conducted a search for potential novel sequence motifs by using MEME software ([@bib1]). Although, as expected, some weak motifs were identified in a subset of candidate gene 3′ flanking regions using this approach (see [Figure S4](#figs4){ref-type="fig"}), their relevance to transcription termination is not clear. Thus our bioinformatic analysis shows that CoTC terminators are not characterized by a simple sequence motif and indicates that factors apart from DNA sequence are involved in the CoTC termination process.

Discussion {#sec3}
==========

Transcription termination is an important, yet relatively overlooked, aspect of the Pol II transcription cycle. Major reasons for this are the considerable technical difficulties involved in the analysis of nascent Pol II transcripts and the fact that Pol II termination has not as yet, been recapitulated in vitro. However, the finding that Pol II transcription termination on the human β-globin gene, which occurs by the CoTC terminator mechanism ([@bib5]), involves release of β-globin pre-mRNA from the chromatin template to the nucleoplasm ([@bib26]) has enabled us to develop a method for identification of Pol II terminator elements. We have conducted IP of nucleoplasmic RNA, using antibody against the pre-mRNA processing factor CstF-64, to select pre-mRNAs that are released from transcription sites prior to 3′ end processing. Mass sequencing of such CstF-64 interacting pre-mRNAs enabled the identification of 78 candidate genes for the CoTC termination pathway. Detailed transcriptional analysis of the 3′ flanking regions of a randomly selected subset of five candidate genes (*CCNB1*, *PTCH2*, *WDR13*, *THOC2*, and *AKIRIN1*), resulted in the identification of CoTC terminator elements located 0.5--2 kb downstream of the candidate gene poly(A) sites. Each terminator element promotes efficient Pol II termination with the most potent, from the *CCNB1* and *PTCH2* gene 3′ flanking regions, mediating 100% Pol II termination in nuclear run on assays. From these results we predict that the remaining 73 candidate genes contain CoTC terminators within their 3′ flanking regions.

Although we have identified CoTC terminators at a number of gene loci, our data indicate that this number is limited because we have not reached saturation in identification of unprocessed pre-mRNAs in the nucleoplasm. This is possibly due to both the relatively low abundance of these species and gene-specific variation in the strength of the poly(A) site-CstF-64 interaction ([@bib21]; [@bib13]). Thus it is likely that many more protein coding genes employ the CoTC termination mechanism. Supporting evidence for this suggestion comes from an electron microscopic study of Pol II transcription in *Drosophila*. In this study, of over 100 unidentified Pol II transcribed genes, it was found that Pol II termination and pre-mRNA release occurred prior to pre-mRNA 3′ end processing for 64% of these genes ([@bib14]). Although the mechanism of Pol II termination at these gene loci is unknown, the observation of abundant released pre-mRNA is suggestive of a CoTC-type termination pathway.

In order to understand more about the possible role of DNA sequence in the CoTC termination mechanism we conducted a detailed bioinformatic analysis of the 3′ flanking regions (0--2 kb downstream of the CLIP-seq sites) of all 78 CoTC candidate genes. From this analysis, we found that these regions are more AT- and T-rich than equally sized regions downstream of the annotated pA sites of other protein coding genes. Although a search for known transcription factor DNA binding motifs in the candidate gene 3′ flanking regions, using the TRANSFAC database (1,665 binding motif matrices), revealed no matches, a search for potential novel sequence motifs using MEME software ([@bib1]) did identify a number of weak motifs in a subset of candidate gene 3′ flanking regions. Further work will be required to determine the importance of these sequence motifs in the CoTC termination process. Combining these data with our understanding of the role of AT-rich sequences in the human β-globin terminator ([@bib5]: [@bib27]) enables us to state that CoTC terminator sequences are complex and are not characterized by a simple sequence motif. An interesting possibility is that the length and sequence composition of CoTC terminator elements may have affects on nucleosome organization ([@bib8]) that may be instrumental in the Pol II termination process.

Apart from mapping CoTC terminators our CLIP-seq strategy illuminates another termination pathway at endogenous gene loci. Analysis of pre-mRNA from the *GAPDH*, *PKM2*, and *ENO1* genes (that were not selected by IP of nucleoplasmic pre-mRNA) shows that for these genes, cotranscriptional poly(A) site cleavage precedes release of Pol II from the chromatin template. Such an order of events corresponds to the pausing model of transcription termination where it is envisioned that G-rich sequences, located immediately downstream of the poly(A) site, cause a transient pause in Pol II progression that effectively enhances 3′ end processing ([@bib6]). In agreement with this model the *GAPDH*, *PKM2*, and *ENO1* genes all have enrichment of G residues in the post poly(A) site region, which correlates with a recent chromatin immunoprecipitation (ChIP) analysis showing significant Pol II accumulation at the 3′ ends of the *GAPDH* and *ENO1* genes ([@bib3]).

Although we have discussed Pol II termination in terms of CoTC and pausing models ([Figure 6](#fig6){ref-type="fig"}) this may be an oversimplification. Results herein and in previous analyses of CoTC sequences, show significant variation in CoTC terminator efficiency ([@bib5]; [@bib15]; [@bib25]). Considering the sequence-specificity of CoTC (AT-rich) and pause (G-rich) terminator elements, it is likely that the relative contribution of each termination mechanism, at individual gene loci, is directed by 3′ flanking region sequence composition. This leads us to speculate that, especially in the light of the observation that CoTC termination can enhance levels of gene expression ([@bib23]), gene-specific 3′ flanking region sequence composition could have subtle, but important, effects on gene expression.

This study marks a successful attempt to map Pol II terminator elements at endogenous gene loci. It has enabled the characterization of a significant number of CoTC terminator elements, which we predict to be a common feature of mammalian genes, and the visualization of a different termination mechanism, possibly pause-type, occurring at gene loci that were not selected using the CLIP-seq methodology. We anticipate that application of the range of techniques described herein will enable the definition of many more terminator elements and lead to a deeper understanding of mammalian Pol II termination pathways and their roles in gene expression.

Experimental Procedures {#sec4}
=======================

PCR Primers and RNA Linkers {#sec4.1}
---------------------------

A list of oligonucleotide sequences used as PCR primers and RNA linkers is given in [Table S1](#mmc1){ref-type="supplementary-material"}.

Plasmid Constructions {#sec4.2}
---------------------

pTat, βTERM, βΔTERM, and β4-7 (formerly βΔ5--7, βΔ5--10, and βΔ8--10) have been described previously ([@bib5]). βCCNB1, βPTCH2, βAKIRIN1, βTHOC2, βWDR13, and βCCNB1/A/B and C expression plasmids were made by insertion of genomic PCR fragments, isolated using gene-specific primer sets, into a cloning vector prepared by long range PCR amplification ([@bib2]) of βΔTERM with primers BETA43/BETA10.3 using PrimeSTAR HS DNA polymerase (Takara).

Transfection Procedure {#sec4.3}
----------------------

Transient transfection of HeLa cells was performed as previously described ([@bib26]).

Nuclear RNA Fractionation {#sec4.4}
-------------------------

Nuclear RNA fractionation was performed as previously described ([@bib26]).

RNA Immunoprecipitation {#sec4.5}
-----------------------

HeLa cells on 10 cm plates were irradiated with 254 nm UV (300 mJ/cm^2^) prior to nuclear fractionation. RNA in the nucleoplasm fraction was immunoprecipitated with either rabbit IgG or CstF-64 antibody (Cambridge Bioscience) conjugated to Protein G Dynabeads (Invitrogen). Following 1 hr incubation at 4°C, beads were washed four times with NET-2 buffer (10 mM Tris-HCl pH7.5, 150 mM NaCl, 0.05% NP-40) and precipitated RNA eluted in Trizol (Invitrogen).

HITS Library Preparation and Data Processing {#sec4.6}
--------------------------------------------

HITS library preparation was performed as described ([@bib11]). Samples from three independent repeats of CstF-64 CLIP-seq were submitted to high-throughput sequencing from the 5′ ends using the Illumina Hi-Seq 100 nt single-end reads protocol (Source Bioscience). Repeats 1 and 2 were multiplexed and sequenced together in the same lane. During pre-processing, samples 1 and 2 were demultiplexed using barcodes; low quality reads (mean Q \< 30 within the first 50 bases) were removed and 3′ sequences matching ligated adaptors or putative oligo-A tails trimmed. Reads shorter than 24 nt were discarded and longer reads trimmed to 50 nt before Bowtie alignment to the hg18 assembly of the human genome allowing for three mismatches. From a total of 97.5 M reads (40.1 M, 32.9 M and 24.5 M, in repeats 1, 2, and 3, respectively), 49.8 M aligned, of which 38.5 M (13.1 M, 10.9 M, and 13.8 M in repeats 1, 2, and 3, respectively) matched unique sites (only these were considered in the subsequent analysis). Each of the experimental repeats resulted in a high level of duplication indicated by many reads aligned to the same genomic location, probably due to the low amount of pre-mRNA targets recovered from the nucleoplasm in the CLIP experiment. To avoid bias PCR duplicates were removed and each unique read-alignment location was considered only once, resulting in 9,658 (3,410, 2,765, and 3,483, in repeats 1, 2, and 3, respectively) read-alignment sites. To maximize sensitivity reads from the three repeats were pooled for subsequent analysis. Overlapping read-alignments (extended by 100 bp) were merged to "regions." A total of 1,285 regions, supported by at least two independent read-alignments, were considered significant. Many regions were identified in only one repeat, indicating that the experiment was far from saturation in detection of nucleoplasmic CstF-64 binding targets. To determine their genomic distribution, significant regions were related to NCBI RNA reference sequences (RefSeq) and short RNA gene (RNA genes) annotation tracks, downloaded from the UCSC genome browser. To identify genes that employ the CoTC termination pathway we selected pre-mRNAs with a CstF-64 CLIP region in 3′ UTRs, extended by 200 bp downstream (to account for variability in poly(A) site usage and imprecision in transcript-end annotation).

RT-PCR and qRT-PCR {#sec4.7}
------------------

cDNA was synthesized using Superscript III (Invitrogen). DNA amplification was performed using Go-Taq DNA polymerase (Promega). When conducting qRT-PCR, PCR products were amplified with \[α-^32^P\]dCTP (Perkin Elmer). PCR products were applied to 6% polyacrylamide gels and radioactive signals quantified by PhosphoImager (Fuji).

RNase Protection Analysis {#sec4.8}
-------------------------

RNase protection analysis is as described previously ([@bib15]).

NRO Analysis and Single-Stranded DNA probes {#sec4.9}
-------------------------------------------

NRO analysis and single-stranded M13 probes used are as described previously ([@bib26]). Quantitation of NRO hybridization signals by PhosphoImager analysis is based on the average of multiple experiments after subtraction of background signal, shown by probe M.

Accession Numbers {#app1}
=================

The sequences generated for this work have been deposited in the Array Express Archive under accession number E-MTAB-1375 (<http://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-1375>).

Supplemental Information {#app3}
========================

Table S1. RNA Linker and DNA Primer List, Related to Experimental ProceduresDocument S1. Article plus Supplemental Information
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![Isolation of Nucleoplasmic CstF-64-Associated Pre-mRNA\
(A) Diagram of the CoTC termination mechanism. The CoTC terminator (red bar) is located downstream of the poly(A) site (pA, green arrowhead) of the human β-globin gene. β-globin pre-mRNA (curved black line with blue cap) is generated by Pol II (gray icons). 3′ flanking region transcripts (red dashed line) are cleaved by CoTC activity (scissors). Xrn2 (blue icon) degrades the 3′ transcript (black dashed line) leading to Pol II and pre-mRNA release from the DNA template. Pre-mRNA is processed by poly(A) factors including CstF-64 (gray sphere) in the nucleoplasm to mRNA (line with AAAA indicating poly(A) tail).\
(B) RT-PCR analysis of immunoprecipitated nucleoplasmic RNA. RNA in control input (lanes 1 and 4) and immunoprecipitated with rabbit IgG (lanes 2 and 5) or CstF-64 antibody (lanes 3 and 6) was subjected to RT-PCR analysis using β-globin-specific primers (blue arrows in diagram beside the data panel) and primers for 7SK snRNA. The lack of bands in lanes 4--6 (−RTase) confirms the absence of contaminating DNA in all samples.\
(C) Purification of CstF-64-RNA covalent complexes by SDS-PAGE following treatment with high (40 U/ml, lanes 1--4) or low (4 U/ml, lanes 5--8) RNaseI. No protein-RNA complexes were detected in the absence of UV irradiation (lanes 1, 2, 5, and 6) or following control immunoprecipitation with rabbit IgG (lanes 3 and 7), demonstrating the specificity of the CstF-64 antibody/CstF-64-RNA complex interaction. The red dashed box, in lane 8, indicates the area of the gel from which CstF-64-RNA complexes were eluted for subsequent HITS analysis.\
(D) Bar graphs showing the distribution of CLIP reads in annotated genic and intergenic regions (left panel) and in intron, exon, and 3′ UTRs of annotated genes (right panel). P values (brackets) for the significance of relative enrichment, with respect to what would be expected by chance, in the case of a random distribution, were calculated using a one-sided binomial test. ^∗^Indicates significant enrichment (p value \< 0.001).\
(E) Diagram of the human β-globin gene with CLIP tags (dark blue squares) mapped to the sequence shown below the diagram. The annotated poly(A) site is indicated in green. Red letters highlight G/U stretches representing potential CstF-64 binding sites.](gr1){#fig1}

![Nuclear Distribution of Pre-mRNA from CstF-64 CLIP Positive and Negative Gene Loci\
CLIP positive (A) and negative (B) gene names are shown to the left of the corresponding data panels. RT-PCR analysis was performed on pre-mRNA from chromatin (Ch, lanes 1 and 3) and nucleoplasm (N, lanes 2 and 4) fractions. cDNA synthesis was primed using random primers, in reactions with (+RTase, lanes 1 and 2) or without (−RTase, lanes 3 and 4) the addition of reverse transcriptase to control for the presence of contaminating DNA. PCR amplification (23 cycles) of the resulting cDNA was conducted using gene-specific primers (indicated by blue arrows in the diagrams above the data panels) spanning annotated poly(A) sites (UCSC Genome Browser; <http://genome.ucsc.edu/>). (The number of PCR cycles was determined to be within the linear range \[data not shown\] and therefore accurately reflects RNA abundance). Radiolabeled RT-PCR products from chromatin and nucleoplasm fractions (lanes 1 and 2) were quantitated by PhosphoImage analysis and the proportion of released nucleoplasmic pre-mRNA (% total) calculated and displayed in the graphs below the data panels. The lack of PCR products in lanes 3 and 4 (−RTase) confirms the absence of contaminating DNA in all samples. The diagrams above the data panels illustrating CoTC-type (A) and pause-type (B) termination mechanisms are labeled as [Figure 1](#fig1){ref-type="fig"}A, except for the pause element (blue bar) and scissors (indicating cleavage by the 3′ end processing complex) in (B). Error bars represent the results of three experimental repeats.](gr2){#fig2}

![Mapping CoTC Terminator Elements at Endogenous Gene Loci\
(A) RT-PCR analysis of *CCNB1* 3′ flanking region transcripts using primer pairs indicated (blue arrows) in the diagram below the data panel. Lanes 1--5, control PCR amplification of genomic DNA. Lanes 6--10 (+RTase) PCR amplification of reverse transcribed *CCNB1* 3′ flanking region transcripts. Lanes 11--15, control PCR amplification of −RTase samples. The diagram below the data panel shows the *CCNB1* 3′ UTR (gray box), poly(A) site (green arrowhead), and putative CoTC terminator element (PCTE, red bar).\
(B) RT-PCR analysis of *PTCH2*, *THOC2*, *AKIRIN1*, and *WDR13* 3′ flanking region transcripts. Sample lanes and diagram notation are as in (A). ^∗^In PTCH2 lane 8, indicates nonspecific RT-PCR products of unknown origin. Control PCR amplification (−RTase, lanes 11--15) confirms the absence of contaminating DNA.\
See also [Figure S1](#figs1){ref-type="fig"}.](gr3){#fig3}

![Measuring Terminator Efficiency\
(A) Diagram of the βΔTERM construct. The transcription start site (gray arrow), poly(A) site (green arrowhead, labeled pA), insertion site of PCTEs, and β-globin terminator (red bar) are indicated. The HIV-LTR antisense riboprobe (tailed rectangle), expected readthrough (RT), and mRNA (P) protection products (blue bars) are also shown.\
(B) RNase protection termination assay (RPA). Lane 1, untransfected cells, lanes 2--8 transfected cells. Control RNase digestion of the riboprobe is shown in lane 9 (tRNA^+^) beside undigested riboprobe (tRNA^−^, lane 10). For each sample RT and P protection products were quantified by PhosphoImage analysis and the relative abundance of the RT product (RT/Total) was calculated and displayed in the graph below the data panel. Error bars represent the results of three experimental repeats.\
(C) Nuclear run on (NRO) analysis of *CCNB1* and *PTCH2* terminator elements. In the diagram, above the data panel, positions of single strand (ss) DNA probes, with respect to the plasmid template, are indicated by characters in bold. Slot blots in the data panel show the distribution of nascent transcripts from the plasmid templates indicated to the left of the panel. The bar graph, below the data panel, shows quantitation of NRO hybridization signals after removal of background hybridization signal, detected by control probe M (M13 DNA), and correction for \[α-^32^P\]UTP content of the hybridized nascent transcripts.](gr4){#fig4}

![Mapping of CoTC Termination Activity in the *CCNB1* 3′ Flanking Region\
(A) Graph showing results of qRT-PCR analysis of transcript distribution (gray bars) and transcript continuity (black bars) at the *CCNB1* gene terminator. Diagrams, below the graph, show primer pairs (blue arrows) used in transcript distribution and transcript continuity analyses. The *CCNB1* poly(A) site (green arrowhead) and terminator element (red bar) are indicated. In the graph, (^∗^) indicates that no PCR product was detected with the indicated primer pairs. Error bars represent the results of three experimental repeats.\
(B) RPA of *CCNB1* terminator fragments. In the diagram of the βΔTERM reporter plasmid, dashed red lines indicate the insertion site of *CCNB1* terminator fragments (labeled colored bars). Lane 1, untransfected cells, lanes 2--7 transfected cells. Control RNase digestion of the riboprobe is shown in lane 8 (tRNA^+^) beside undigested riboprobe (tRNA^−^, lane 9). For each sample RT and P protection products were quantified by PhosphoImage analysis and the relative abundance of the RT product (RT/Total) was calculated and displayed in the graph below the data panel. Error bars represent the results of three experimental repeats.\
(C) qRT-PCR analysis of the continuity of *CCNB1* terminator subfragment transcripts. In the diagram, the location of PCR primers (red and blue arrows), relative to terminator fragments (red bar) is shown. Lane 1, qRT-PCR of untransfected cells. Lanes 2--4, cells transfected with *CCNB1* terminator fragment constructs. Lanes 5--8, control qRT-PCR of −RTase samples. cDNA in all samples was amplified using 15 PCR cycles (data not shown), which was determined to be within the linear range and therefore accurately reflects RNA abundance.\
See also [Figure S2](#figs2){ref-type="fig"}.](gr5){#fig5}

![Diagram of CoTC and Pause-Type Pol II Termination Pathways\
In the CoTC termination pathway transcripts of AT-rich terminator elements (red bar) are cleaved by CoTC activity (red scissors) promoting Pol II release before poly(A) site cleavage, mediated by the 3′ processing complex (green scissors). In the pause-type termination pathway, Pol II transcriptional pausing, at G-rich sequences (blue bar), enhances pre-mRNA cleavage at the poly(A) site, leading to Pol II release. Icons and symbols as in [Figure 1](#fig1){ref-type="fig"}A.](gr6){#fig6}

![Control Experiment to Test RT-PCR Efficiency on PCTE Transcripts, Related to [Figure 3](#fig3){ref-type="fig"}\
(A) Diagram showing candidate gene PCTEs (red box), control T7 transcripts (black line) and PCR primers (blue arrows). The gene specific PCR primer sets used are as in [Figure 3](#fig3){ref-type="fig"}.\
(B) Data from RT-PCR analysis of *CCNB1*, *PTCH2* and *WDR13* PCTEs. Full length T7 PCTE transcripts and PCTE transcripts from HeLa cell nuclei were reverse transcribed with random primers. The resulting cDNAs were PCR amplified (26 PCR cycles for T7 RNA templated cDNA and 32 cycles for HeLa nuclear RNA templated cDNA) using indicated gene specific primer pairs. Lanes 1-3, RT-PCR products from T7 PCTE transcripts. The presence of the prominent, expected, PCR products (indicated by red arrows) in each lane indicates that the control T7 PCTE transcripts are efficiently reverse transcribed and PCR amplified, irrespective of their length. Lanes 4-6, RT-PCR products from HeLa nuclear PCTE transcripts. Prominent bands, corresponding to the 5′ end of PCTE transcripts, are detected in lane 4 for all samples, however RT-PCR products representing longer PCTE transcripts, in lanes 5 and 6, are of lower abundance and in some cases entirely absent (e.g., *CCNB1*, lane 6). Comparison of HeLa nuclear PCTE transcript RT-PCR products (in lanes 4-6) with RT-PCR products from control T7 transcripts (lanes 1-3) shows that detection of longer endogenous nuclear transcripts is significantly lower than for the corresponding T7 control transcripts. This result indicates that the longer PCTE transcripts are less abundant in HeLa nuclei, due to transcript termination or transcript cleavage, rather than template length dependent decrease in RT-PCR efficiency. The absence of PCR products in control lanes 7-9 (-RTase) confirms the absence of contaminating DNA in these experiments.](figs1){#figs1}

![*WDR13* 3′ Flanking Region Transcript Distribution and Continuity, Related to [Figure 5](#fig5){ref-type="fig"}\
(A) Transcript distribution. The diagram above the data panel shows the *WDR13* 3′ flanking region, including the poly(A) site (green arrowhead) and terminator element (red box). Primers used in qRT-PCR analysis are indicated by blue arrows. Lanes 1-4, control qPCR amplification of genomic DNA. Lanes 5-9, qRT-PCR of *WDR13* 3′ flanking region transcripts. Lanes 9-12, control qRT-PCR of -RTase samples. (^∗^) the high Mw qRT-PCR products in lane 7 are non specific RT-PCR products of unknown origin.\
(B) Transcript continuity. Diagram labeled as in (A), with addition of scissors indicating CoTC. Lanes 1-3, control qPCR amplification of genomic DNA. Lanes 4-6, qRT-PCR of *WDR13* 3′ flanking region transcripts. Lanes 7-9, control qRT-PCR of -RTase samples.\
(C) Bar graph showing quantitative analysis of *WDR13* 3′ flanking region transcript distribution (gray bars) and continuity (black bars). Transcript abundance was calculated by phosphoImage quantitation of radioactive qRT-PCR products (+RTase lanes in (A) and (B)), normalized to products resulting from qPCR amplification of corresponding genomic DNA sequences (Genome lanes in (A) and (B)). The transcript distribution data show that transcript abundance decreases to low levels at the 3′ end of the terminator element, presumably due to the occurrence of Pol II termination. The transcript continuity data shows that although some continuous transcripts are detected at the 5′ end of the terminator, the level of continuous transcripts decreases markedly beyond this point. These data indicate that nascent transcripts of the 5′ end of the *WDR13* terminator are co-transcriptionally cleaved and, when combined with results from the measurement of transcript distribution above, indicate that transcript cleavage precedes Pol II termination occurring throughout the *WDR13* terminator. This profile of transcript discontinuity followed by Pol II termination is similar to that described for the human β-globin gene terminator ([@bib5]) and *CCNB1* terminator ([Figure 5](#fig5){ref-type="fig"}A) and is indicative of the presence of the CoTC termination mechanism at the *WDR13* gene locus. Error bars represent the results of three experimental repeats.](figs2){#figs2}

![Nucleotide Composition of CoTC Terminators, Related to [Results](#sec2){ref-type="sec"}\
Comparison of the nucleotide composition of the sense strand of the putative CoTC terminator regions; 2Kb downstream of the CLIP-seq sites, for 78 CoTC candidate genes (dark gray) and 2Kb downstream of annotated pA sites for 500 randomly selected protein coding genes (white). Boxes show upper and lower quartiles, black lines represent medians. t test p-values are shown in parenthesis below.](figs3){#figs3}

![Result of Search for Potential Novel Sequence Motifs Using MEME Software, Related to [Results](#sec2){ref-type="sec"} and [Discussion](#sec3){ref-type="sec"}\
Putative CoTC terminator regions (2Kb downstream of the CLIP-seq sites for the 78 CoTC candidate genes) were analyzed for the presence of shared motifs using position specific priors based on a negative sequence set (2Kb downstream of annotated pA sites for 500 randomly selected protein coding genes). The top three motifs are shown, together with p-values and number of sequences in which they were found. While as expected several motifs are identified by this approach, their relevance is questionable as they only occur in a subset of candidates ('zoops' mode). No strong motif was present in all candidates ('oops' mode).](figs4){#figs4}

###### 

List of CLIP-Seq-Positive CoTC Candidate Genes

  Gene Symbol   Transcript_ID   Gene Name
  ------------- --------------- -----------------------------------------------------------------------------------------------------------------------------------
  *AGFG1*       NM_004504       ArfGAP with FG repeats 1
  *AKIRIN1*     NM_001136275    akirin 1
  *BCAP29*      NM_001008405    B cell receptor-associated protein 29
  *BLCAP*       NM_006698       bladder cancer-associated protein
  *BRD9*        NM_001009877    bromodomain containing 9
  *C5orf28*     NM_022483       chromosome 5 open reading frame 28
  *C5orf35*     NM_153706       chromosome 5 open reading frame 35
  *CANX*        NM_001746       Calnexin
  *CCDC72*      NM_015933       coiled-coil domain containing 72
  *CCNB1*       NM_031966       cyclin B1
  *CD55*        NM_001114752    CD55 molecule, decay accelerating factor for complement (Cromer blood group)
  *CELF1*       NM_001172640    CUGBP Elav-like family member 1
  *CHST15*      NM_015892       carbohydrate (N-acetylgalactosamine 4-sulfate 6-O) sulfotransferase 15
  *CYBRD1*      NM_024843       cytochrome b reductase 1
  *CYFIP1*      NM_014608       cytoplasmic FMR1 interacting protein 1
  *DDX3X*       NM_001356       DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, X-linked
  *DDX58*       NM_014314       DEAD (Asp-Glu-Ala-Asp) box polypeptide 58
  *DMD*         NM_004019       Dystrophin
  *DNAJC6*      NM_014787       DnaJ (Hsp40) homolog, subfamily C, member 6
  *FAM200B*     NM_001145191    family with sequence similarity 200, member B
  *FAR1*        NM_032228       fatty acyl CoA reductase 1
  *GNAI3*       NM_006496       guanine nucleotide binding protein (G protein), α inhibiting activity polypeptide 3
  *GNB2L1*      NM_006098       guanine nucleotide binding protein (G protein), β polypeptide 2-like 1
  *HADHA*       NM_000182       hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-Coenzyme A thiolase/enoyl-Coenzyme A hydratase (trifunctional protein), α subunit
  *HBB*         NM_000518       hemoglobin, β
  *HES7*        NM_001165967    hairy and enhancer of split 7 (*Drosophila*)
  *HN1L*        NM_144570       hematological and neurological expressed 1-like
  *HNRNPD*      NM_031369       heterogeneous nuclear ribonucleoprotein D (AU-rich element RNA binding protein 1, 37 kDa)
  *HNRNPM*      NM_031203       heterogeneous nuclear ribonucleoprotein M
  *IRX3*        NM_024336       iroquois homeobox 3
  *KCMF1*       NM_020122       potassium channel modulatory factor 1
  *KLF6*        NM_001160125    Kruppel-like factor 6
  *MAFK*        NM_002360       v-maf musculoaponeurotic fibrosarcoma oncogene homolog K (avian)
  *MARK3*       NM_001128920    MAP/microtubule affinity-regulating kinase 3
  *MIB1*        NM_020774       mindbomb homolog 1 (*Drosophila*)
  *MRPL30*      NM_145212       mitochondrial ribosomal protein L30
  *MRPS14*      NM_022100       mitochondrial ribosomal protein S14
  *MYC*         NM_002467       v-myc myelocytomatosis viral oncogene homolog (avian)
  *NCS1*        NM_001128826    frequenin homolog (*Drosophila*)
  *NQO2*        NM_000904       NAD(P)H dehydrogenase, quinone 2
  *NUCKS1*      NM_022731       nuclear casein kinase and cyclin-dependent kinase substrate 1
  *NUFIP2*      NM_020772       nuclear fragile X mental retardation protein interacting protein 2
  *OMA1*        NM_145243       OMA1 homolog, zinc metallopeptidase (*Saccharomyces cerevisiae*)
  *PRPF4B*      NM_003913       similar to hCG1820375; PRP4 pre-mRNA processing factor 4 homolog B (yeast)
  *PSIP1*       NM_021144       PC4 and SFRS1 interacting protein 1
  *PTCH2*       NM_001166292    patched homolog 2 (*Drosophila*)
  *RAB13*       NM_002870       RAB13, member RAS oncogene family; similar to hCG24991
  *RAPH1*       NM_213589       Ras association (RalGDS/AF-6) and Pleckstrin homology domains 1
  *RBM27*       NM_018989       RNA binding motif protein 27
  *RNASEH1*     NM_002936       ribonuclease H1
  *RNF166*      NM_178841       ring finger protein 166
  *RPL13A*      NM_012423       ribosomal protein L13a pseudogene
  *RPL37A*      NM_000998       ribosomal protein L37a
  *RRP15*       NM_016052       ribosomal RNA processing 15 homolog (*S. cerevisiae*)
  *SAC3D1*      NM_013299       SAC3 domain containing 1
  *SAP18*       NM_005870       Sin3A-associated protein, 18 kDa
  *SCAF8*       NM_014892       RNA binding motif protein 16
  *SCLT1*       NM_144643       sodium channel and clathrin linker 1
  *SIK1*        NM_173354       salt-inducible kinase 1
  *TEAD1*       NM_021961       TEA domain family member 1 (SV40 transcriptional enhancer factor)
  *TFAP2A*      NM_001042425    transcription factor AP-2 α (activating enhancer binding protein 2 α)
  *THOC2*       NM_001081550    THO complex 2
  *TNRC6A*      NM_014494       trinucleotide repeat containing 6A
  *TROAP*       NM_001100620    trophinin-associated protein (tastin)
  *TUBA1B*      NM_006082       hypothetical gene supported by AF081484; NM_006082; tubulin,α 1b
  *TXLNG*       NM_001168683    γ-taxilin
  *TXNRD1*      NM_001093771    thioredoxin reductase 1; hypothetical LOC100130902
  *WDR13*       NM_001166426    WD repeat domain 13
  *WDR36*       NM_139281       WD repeat domain 36
  *WNK1*        NM_014823       WNK lysine deficient protein kinase 1
  *YWHAZ*       NM_145690       tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, ζ polypeptide
  *ZAK*         NM_133646       sterile α motif and leucine zipper containing kinase AZK
  *ZBTB9*       NM_152735       zinc finger and BTB domain containing 9
  *ZDHHC7*      NM_001145548    zinc finger, DHHC-type containing 7
  *ZNF215*      NM_013250       zinc finger protein 215
  *ZNF616*      NM_178523       zinc finger protein 616
  *ZNF714*      NM_182515       zinc finger protein 714
  *ZNF740*      NM_001004304    zinc finger protein 740

List of nonredundant RefSeq protein-coding genes containing CstF-64 CLIP regions (supported by at least two read-alignments) within poly(A) site regions (extended 200 nt downstream). These genes represent candidates for the CoTC termination mechanism. "Ribonucleoprotein complex" and "RNA binding" GO-TERMs were significantly enriched (Benjamini \< 0.05) among these genes (DAVID Bioinformatics Resources). HBB derives from CLIP1 where cells were transfected with the β-globin expression plasmid βTERM.
